Skip to content

Ping An Biomedical Co., Ltd.: 20-F filed 2026-01-30

What Ping An Biomedical Co., Ltd. reported in its annual report (foreign private issuer) filed 2026-01-30 (fiscal FY 2025): 47 published measures, 168 facts as tagged in accession 0001213900-26-010078.

This filing

Form
20-F (annual report (foreign private issuer))
Filed
2026-01-30
Fiscal period
fiscal FY 2025
Accession
0001213900-26-010078 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Ping An Biomedical Co., Ltd. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-3068,414,527CNY
At 2024-09-3056,849,755CNY
At 2025-09-309,610,131USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-3023,172,520CNY
At 2024-09-3064,037,936CNY
At 2025-09-303,255,025USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-3045,242,007CNY
At 2024-09-30-7,188,181CNY
At 2023-09-30-5,859,593CNY
At 2022-09-304,599,545CNY
At 2025-09-306,355,106USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-09-301,172,480CNY
At 2024-09-30130,923CNY
At 2023-09-30591,874CNY
At 2025-09-30164,697USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-10-01 to 2025-09-30-12,829,206CNY365
2023-10-01 to 2024-09-30-1,284,172CNY366
2022-10-01 to 2023-09-30-993,937CNY365
2024-10-01 to 2025-09-30-1,802,108USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-10-01 to 2025-09-30-6,427,762CNY365
2023-10-01 to 2024-09-3014,630,221CNY366
2022-10-01 to 2023-09-30-6,082,836CNY365
2024-10-01 to 2025-09-30-902,902USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2024-10-01 to 2025-09-3034,147,936CNY365
2023-10-01 to 2024-09-3087,622,395CNY366
2022-10-01 to 2023-09-3082,563,751CNY365
2024-10-01 to 2025-09-304,796,732USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-10-01 to 2025-09-3043,660,424CNY365
2023-10-01 to 2024-09-30-30,088,905CNY366
2022-10-01 to 2023-09-308,874,664CNY365
2024-10-01 to 2025-09-306,132,944USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-10-01 to 2025-09-300CNY365
2023-10-01 to 2024-09-3015,000,000CNY366
2022-10-01 to 2023-09-30-3,367,570CNY365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-21,047,417CNY
At 2024-09-30-8,218,211CNY
At 2025-09-30-2,956,513USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-10-01 to 2025-09-3018,479,452shares365
2023-10-01 to 2024-09-3018,000,000shares366
2022-10-01 to 2023-09-3018,000,000shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-10-01 to 2025-09-3018,479,452shares365
2023-10-01 to 2024-09-3018,000,000shares366
2022-10-01 to 2023-09-3018,000,000shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-10-01 to 2025-09-30-0.69CNY/shares365
2023-10-01 to 2024-09-30-0.07CNY/shares366
2022-10-01 to 2023-09-30-0.06CNY/shares365
2024-10-01 to 2025-09-30-0.1USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-10-01 to 2025-09-30-0.69CNY/shares365
2023-10-01 to 2024-09-30-0.07CNY/shares366
2022-10-01 to 2023-09-30-0.06CNY/shares365
2024-10-01 to 2025-09-30-0.1USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-10-01 to 2025-09-301,855,589CNY365
2023-10-01 to 2024-09-30-601,456CNY366
2022-10-01 to 2023-09-30-1,035,623CNY365
2024-10-01 to 2025-09-30260,653USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-09-305,585CNY

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-10-01 to 2025-09-30-14,701,471CNY365
2023-10-01 to 2024-09-30-2,039CNY366
2022-10-01 to 2023-09-30612,481CNY365
2024-10-01 to 2025-09-30-2,065,103USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-3063,697,447CNY
At 2024-09-3053,310,118CNY
At 2025-09-308,947,527USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-3023,076,822CNY
At 2024-09-3063,576,483CNY
At 2025-09-303,241,582USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-09-309,413,410CNY
At 2024-09-3015,055,820CNY
At 2025-09-301,322,294USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-09-3016,930,876CNY
At 2024-09-3040,441,296CNY
At 2025-09-302,378,266USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-10-01 to 2025-09-3015,650,976CNY365
2023-10-01 to 2024-09-305,418,926CNY366
2022-10-01 to 2023-09-303,627,687CNY365
2024-10-01 to 2025-09-302,198,479USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-09-30441,904CNY
At 2024-09-30127,296CNY
At 2025-09-3062,074USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-10-01 to 2025-09-30949,505CNY365
2023-10-01 to 2024-09-305,416,887CNY366
2022-10-01 to 2023-09-304,240,168CNY365
2024-10-01 to 2025-09-30133,376USD365

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2024-10-01 to 2025-09-3033,198,431CNY365
2023-10-01 to 2024-09-3082,205,508CNY366
2022-10-01 to 2023-09-3078,323,583CNY365
2024-10-01 to 2025-09-304,663,356USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-3020,500,000shares
At 2024-09-3018,000,000shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-09-3036,696,290CNY
At 2024-09-30130,923CNY
At 2023-09-30591,874CNY
At 2022-09-301,166,538CNY
At 2025-09-305,154,697USD
At 2024-09-3018,391USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2025-09-30-1,611,000CNY
At 2024-09-30-656,670CNY
At 2025-09-30-226,297USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-09-30467,577CNY
At 2024-09-30811,819CNY
At 2025-09-3065,680USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-09-30467,577CNY
At 2024-09-30811,819CNY
At 2025-09-3065,681USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-09-3099,255CNY
At 2024-09-3099,255CNY
At 2025-09-3013,942USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-09-3099,255CNY
At 2024-09-3093,670CNY
At 2025-09-3013,942USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-09-309,628,377CNY
At 2024-09-3012,603,304CNY
At 2025-09-301,352,490USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2025-09-3069,776CNY
At 2024-09-301,673,479CNY
At 2025-09-309,801USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2025-09-304,249,503CNY
At 2024-09-302,722,233CNY
At 2023-09-302,730,500CNY
At 2022-09-302,723,041CNY
At 2025-09-30596,924USD
At 2024-09-30382,390USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-10-01 to 2025-09-30-14,684,795CNY365
2023-10-01 to 2024-09-30-682,716CNY366
2022-10-01 to 2023-09-3041,686CNY365
2024-10-01 to 2025-09-30-2,062,761USD365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2024-10-01 to 2025-09-30-13,783,536CNY365
2023-10-01 to 2024-09-30-1,014,361CNY366
2022-10-01 to 2023-09-30-855,408CNY365
2024-10-01 to 2025-09-30-1,936,162USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-10-01 to 2025-09-306,007,792CNY365
2023-10-01 to 2024-09-304,992,481CNY366
2022-10-01 to 2023-09-303,265,341CNY365
2024-10-01 to 2025-09-30843,909USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2024-10-01 to 2025-09-305,585CNY365
2023-10-01 to 2024-09-3010,239CNY366
2022-10-01 to 2023-09-3032,756CNY365
2024-10-01 to 2025-09-30785USD365

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2024-10-01 to 2025-09-30307,055CNY365
2023-10-01 to 2024-09-30705,273CNY366
2022-10-01 to 2023-09-301,740,259CNY365
2024-10-01 to 2025-09-3043,132USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-10-01 to 2025-09-3016,676CNY365
2023-10-01 to 2024-09-30-680,677CNY366
2022-10-01 to 2023-09-30-570,795CNY365
2024-10-01 to 2025-09-302,342USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2024-10-01 to 2025-09-30328,319CNY365
2023-10-01 to 2024-09-30-593,189CNY366
2022-10-01 to 2023-09-30-1,043,082CNY365
2024-10-01 to 2025-09-3046,119USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2024-10-01 to 2025-09-30310,891CNY365
2023-10-01 to 2024-09-30705,274CNY366
2022-10-01 to 2023-09-301,950,750CNY365
2024-10-01 to 2025-09-3043,671USD365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2023-10-01 to 2024-09-30-220,865CNY366
2022-10-01 to 2023-09-302,124,332CNY365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-10-01 to 2025-09-30-14,167,194CNY365
2023-10-01 to 2024-09-30-6,529,361CNY366
2022-10-01 to 2023-09-30-9,875,982CNY365
2024-10-01 to 2025-09-30-1,990,054USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2024-10-01 to 2025-09-30308,473CNY365
2023-10-01 to 2024-09-30-3,055,501CNY366
2022-10-01 to 2023-09-30-1,437,088CNY365
2024-10-01 to 2025-09-3043,331USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2024-10-01 to 2025-09-30-5,642,409CNY365
2023-10-01 to 2024-09-305,783,431CNY366
2022-10-01 to 2023-09-30-8,762,971CNY365
2024-10-01 to 2025-09-30-792,584USD365

Inspect the source

Entity
Ping An Biomedical Co., Ltd. / CIK 0001897532
Captured
2026-09-21T17:34:00.534Z
SEC response SHA-256
7734ffb8d1d293723b67399385bbe52c214be661968d4b0858e737909103f353

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001897532.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))